Difference between revisions of "Comment Resolutions"
Jump to navigation
Jump to search
m |
|||
Line 127: | Line 127: | ||
| 2023.02.07 | | 2023.02.07 | ||
| [[Media:QIBA US SWS Comments 2023-02-20-v2.xlsx| Clinically Feasible Comment Resolutions 2023-02-20]] | | [[Media:QIBA US SWS Comments 2023-02-20-v2.xlsx| Clinically Feasible Comment Resolutions 2023-02-20]] | ||
+ | |- | ||
+ | | [[Media:QIBA US SWS Profile 2023-02-07.pdf|US Shear Wave Speed for Liver Fibrosis 2023-02-07]] | ||
+ | | Clinically Feasible | ||
+ | | 2023.02.07 | ||
+ | | [[Media:QIBA US SWS Comments 2023-02-20-v2.xlsx| Clinically Feasible Comment Resolutions 2023-12-13]] | ||
|- | |- | ||
|} | |} |
Revision as of 15:21, 14 December 2023
Comments received during Public Comment, Clinically Feasible (formerly Technical) Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.
Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.